Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
In a statement sent to Reuters, Novartis did not confirm the value of the deal but said Siemens Healthineers would remain a partner in the Novartis radioligand therapy business, adding that it expects the transaction to close in the fourth quarter.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Sumber: YahooFinanceCA - 🏆 47. / 63 Baca lebih lajut »
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Sumber: YahooFinanceCA - 🏆 47. / 63 Baca lebih lajut »
A German diaspora in North Carolina is booming thanks to a multibillion-dollar investment from Germany, but a potential Trump Presidency is causing anxietyThousands of Germans have flocked to North Carolina in recent years, aided by investments from Siemens and Daimler.
Sumber: YahooFinanceCA - 🏆 47. / 63 Baca lebih lajut »